Philadelphia location 2 — Philadelphia, Pennsylvania

Philadelphia location 2 is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Philadelphia location 2 has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration.

Sponsors: REGENXBIO Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Philadelphia location 2?

Philadelphia location 2 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Philadelphia location 2 conducted?

Philadelphia location 2 has 1 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration.

Is Philadelphia location 2 accredited by Crixeo Health?

Philadelphia location 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Philadelphia location 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.